• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性皮质类固醇治疗并发中心性浆液性脉络膜视网膜病变

Central serous chorioretinopathy complicating systemic corticosteroid therapy.

作者信息

Abu el-Asrar A M

机构信息

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Eur J Ophthalmol. 1997 Jul-Sep;7(3):297-300. doi: 10.1177/112067219700700317.

DOI:10.1177/112067219700700317
PMID:9352287
Abstract

PURPOSE

To present evidence that systemic corticosteroid therapy may cause central serous chorioretinopathy.

METHODS

A 20-year-old male with idiopathic thrombocytopenic purpura was examined during systemic treatment with corticosteroids (100 mg daily).

RESULTS

The patient had central serous chorioretinopathy. Spontaneous recovery accompanied discontinuation of the steroid treatment.

CONCLUSIONS

This case provides further evidence that cortisol may play a role in the development of central serous chorioretinopathy.

摘要

目的

提供证据证明全身用皮质类固醇疗法可能导致中心性浆液性脉络膜视网膜病变。

方法

一名20岁特发性血小板减少性紫癜男性患者在接受皮质类固醇全身治疗(每日100毫克)期间接受检查。

结果

该患者患有中心性浆液性脉络膜视网膜病变。随着类固醇治疗的停止,病情自发恢复。

结论

该病例进一步证明皮质醇可能在中心性浆液性脉络膜视网膜病变的发生中起作用。

相似文献

1
Central serous chorioretinopathy complicating systemic corticosteroid therapy.系统性皮质类固醇治疗并发中心性浆液性脉络膜视网膜病变
Eur J Ophthalmol. 1997 Jul-Sep;7(3):297-300. doi: 10.1177/112067219700700317.
2
Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.糖皮质激素治疗并发日光性视网膜病变的中心性浆液性脉络膜视网膜病变。
Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):166-8. doi: 10.1007/s004170050213.
3
Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.中心性浆液性脉络膜视网膜病变中的纤维化瘢痕形成发生于全身使用皮质类固醇治疗期间。
Graefes Arch Clin Exp Ophthalmol. 1998 Nov;236(11):876-9. doi: 10.1007/s004170050174.
4
Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy.接受全身皮质类固醇治疗患者的中心性浆液性脉络膜视网膜病变
Can J Ophthalmol. 2005 Apr;40(2):217-21. doi: 10.1016/S0008-4182(05)80040-7.
5
Corticosteroid-induced central serous chorioretinopathy.皮质类固醇诱导的中心性浆液性脉络膜视网膜病变
Jpn J Ophthalmol. 1997 May-Jun;41(3):180-5. doi: 10.1016/s0021-5155(97)00027-0.
6
Central serous chorioretinopathy in women.女性中心性浆液性脉络膜视网膜病变
Ophthalmology. 1996 Jan;103(1):72-9. doi: 10.1016/s0161-6420(96)30730-6.
7
Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection.硬膜外注射类固醇后出现类似中心性浆液性脉络膜视网膜病变的双侧浆液性视网膜脱离。
Retina. 1998;18(5):479-81. doi: 10.1097/00006982-199805000-00020.
8
Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.双侧大疱性渗出性视网膜脱离,为全身皮质类固醇治疗期间特发性中心性浆液性脉络膜视网膜病变的并发症。
Ophthalmology. 1995 May;102(5):737-47. doi: 10.1016/s0161-6420(95)30960-8.
9
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.与吸入性或鼻内用皮质类固醇相关的中心性浆液性脉络膜视网膜病变
Ophthalmology. 1997 Oct;104(10):1653-60. doi: 10.1016/s0161-6420(97)30082-7.
10
Central serous chorioretinopathy after epidural corticosteroid injection.硬膜外注射皮质类固醇激素后发生的中心性浆液性脉络膜视网膜病变。
Am J Ophthalmol. 2001 Sep;132(3):423-5. doi: 10.1016/s0002-9394(01)00970-9.

引用本文的文献

1
Diagnosis and Treatment of Central Serous Chorioretinopathy in Patients with Scleritis.巩膜炎患者中心性浆液性脉络膜视网膜病变的诊断与治疗。
Medicina (Kaunas). 2023 May 15;59(5):949. doi: 10.3390/medicina59050949.
2
COVID-19 Vaccine-Related Vogt-Koyanagi-Harada Disease Complicated by Central Serous Chorioretinopathy during Treatment Course: Case Report and Literature Review.COVID-19疫苗相关的葡萄膜炎-小柳原田病在治疗过程中并发中心性浆液性脉络膜视网膜病变:病例报告及文献综述
Vaccines (Basel). 2022 Oct 25;10(11):1792. doi: 10.3390/vaccines10111792.
3
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy.
类固醇相关的中心性浆液性脉络膜视网膜病变的视网膜和脉络膜变化
Int J Retina Vitreous. 2018 Apr 2;4:11. doi: 10.1186/s40942-018-0115-1. eCollection 2018.
4
The relation of somatotypes and stress response to central serous chorioretinopathy.体型和应激反应与中心性浆液性脉络膜视网膜病变的关系。
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2307-2315. doi: 10.1007/s00417-017-3787-6. Epub 2017 Sep 5.
5
Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).半剂量维替泊芬光动力疗法治疗中心性浆液性脉络膜视网膜病变的长期疗效(美国眼科学会论文)
Trans Am Ophthalmol Soc. 2015;113:T8.
6
Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.中心性浆液性脉络膜视网膜病变误诊为后葡萄膜炎及糖皮质激素治疗的恶性循环
J Ophthalmic Vis Res. 2015 Jul-Sep;10(3):303-8. doi: 10.4103/2008-322X.170352.
7
Central serous chorioretinopathy: update on pathophysiology and treatment.中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
8
Central serous chorioretinopathy mistaken for tuberculous choroiditis.中心性浆液性脉络膜视网膜病变误诊为结核性脉络膜炎。
J Ophthalmic Vis Res. 2011 Oct;6(4):334-7.
9
Acute visual loss induced by dexamethasone during neoadjuvant docetaxol.新辅助多西他赛治疗期间地塞米松引起的急性视力丧失
Clin Med Oncol. 2008;2:37-42. doi: 10.4137/cmo.s339. Epub 2008 Feb 9.
10
Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.特发性中心性浆液性脉络膜视网膜病变患者血清皮质醇和睾酮水平。
Indian J Ophthalmol. 2009 Nov-Dec;57(6):419-22. doi: 10.4103/0301-4738.57143.